CHIAPPELLA, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 632
EU - Europa 327
AS - Asia 279
SA - Sud America 5
AF - Africa 3
OC - Oceania 1
Totale 1.247
Nazione #
US - Stati Uniti d'America 609
CN - Cina 200
IT - Italia 103
IE - Irlanda 61
SE - Svezia 39
CA - Canada 23
JP - Giappone 22
FR - Francia 21
GB - Regno Unito 17
SG - Singapore 16
DE - Germania 15
IN - India 13
AT - Austria 10
CH - Svizzera 9
KR - Corea 8
RU - Federazione Russa 8
UA - Ucraina 8
ES - Italia 7
VN - Vietnam 6
HU - Ungheria 5
NL - Olanda 5
GR - Grecia 4
PL - Polonia 4
FI - Finlandia 3
IR - Iran 3
PK - Pakistan 3
SN - Senegal 3
TR - Turchia 3
BE - Belgio 2
BR - Brasile 2
CL - Cile 2
DK - Danimarca 2
TW - Taiwan 2
AU - Australia 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 1.247
Città #
Chandler 109
Dublin 61
Beijing 51
Torino 41
Fairfield 35
Ashburn 30
Houston 29
Redwood City 27
Shanghai 24
Nyköping 23
Duncan 19
Wilmington 19
Dearborn 16
Medford 16
Woodbridge 14
Guangzhou 13
Princeton 13
Ann Arbor 12
Singapore 11
Seattle 10
Vienna 10
Cambridge 9
Hebei 9
Mississauga 9
Chengdu 8
Guiyang 8
Tokyo 8
Villeurbanne 8
New York 7
Boston 6
Jinan 6
Nanjing 6
Pisa 6
Changsha 5
Munich 5
Washington 5
Fremont 4
Hefei 4
Moscow 4
Norwalk 4
Paris 4
Seoul 4
Warsaw 4
Xian 4
Boves 3
Columbus 3
Fuzhou 3
Geneva 3
Hangzhou 3
Portland 3
Somerset 3
Vancouver 3
Zhengzhou 3
Austin 2
Bath 2
Bengaluru 2
Budapest 2
Buffalo 2
Chennai 2
Chicago 2
Delhi 2
Des Moines 2
Dong Ket 2
Durham 2
Harbin 2
Jacksonville 2
Kish 2
Lausanne 2
Madrid 2
Ottawa 2
Raritan 2
Rochester 2
San Diego 2
San Francisco 2
San Mateo 2
Surrey 2
Taipei 2
Talca 2
Tianjin 2
Toronto 2
Upper Marlboro 2
Verona 2
Woodbury 2
Wuhan 2
Zurich 2
Ans 1
Ascoli Piceno 1
Barcelona 1
Bethesda 1
Bologna 1
Brussels 1
Bucharest 1
Burlington 1
Casperia 1
Central District 1
Changchun 1
Cheboksary 1
Chongqing 1
Cincinnati 1
Collegeville 1
Totale 826
Nome #
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma 431
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials 147
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma 126
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi 97
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 75
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue 69
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 65
Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation 64
Epigenomic evolution in diffuse large B-cell lymphomas 62
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial 43
Khorana score and histotype predicts incidence of early venous thromboembolism in Non-Hodgkin lymphomas: A Pooled-Data analysis of 12 clinical trials of fondazione italiana linfomi (FIL) 41
Allogeneic stem cell transplantation in mantle cell lymphoma in the era of new drugs and CAR-T cell therapy 37
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 32
Procalcitonin as a predictive marker of infections in chemoinduced neutropenia 3
Totale 1.292
Categoria #
all - tutte 3.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020132 5 0 4 9 3 19 15 14 21 18 18 6
2020/2021114 9 8 12 21 5 6 6 3 10 11 4 19
2021/2022533 13 43 49 58 54 38 48 46 41 30 64 49
2022/2023289 23 35 12 36 13 69 30 12 26 9 14 10
2023/2024124 13 29 10 11 7 18 3 3 0 8 9 13
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.292